NCT00302445View on ClinicalTrials.gov

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

July 31, 2007

Conditions
Plaque Psoriasis
Interventions
DRUG

Efalizumab

DEVICE

Narrow Band Phototherapy

Trial Locations (2)

40217

Derm Research, PLLC, Louisville

98101

Dermatology Associates, PLLC, Seattle

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Dermatology Associates, PLLC

UNKNOWN

collaborator

Genentech, Inc.

INDUSTRY

lead

Derm Research, PLLC

OTHER